Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Harry J LongGynecologic Oncology Group Study

Abstract

On the basis of reported activity of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) or topotecan plus cisplatin in advanced cervix cancer, we undertook a randomized trial comparing these combinations versus cisplatin alone, to determine whether survival is improved with either combination compared with cisplatin alone, and to compare toxicities and quality of life (QOL) among the regimens. Eligible patients were randomly allocated to receive cisplatin 50 mg/m(2) every 3 weeks (CPT); cisplatin 50 mg/m(2) day 1 plus topotecan 0.75 mg/m(2) days 1 to 3 every 3 weeks (CT); or methotrexate 30 mg/m(2) days 1, 15, and 22, vinblastine 3 mg/m(2) days 2, 15, and 22, doxorubicin 30 mg/m(2) day 2, and cisplatin 70 mg/m(2) day 2 every 4 weeks (MVAC). Survival was the primary end point; response rate and progression-free survival (PFS) were secondary end points. QOL data are reported separately. The MVAC arm was closed by the Data Safety Monitoring Board after four treatment-related deaths occurred among 63 patients, and is not included in this analysis. Two hundred ninety-four patients enrolled onto the remaining regimens: 146 to CPT and 147 to CT. Grade 3 to 4 hematologic toxicity was more common with CT. Patients receiving CT...Continue Reading

References

Mar 1, 1989·Journal of the National Cancer Institute·E J BuxtonD M Luesley
Dec 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F B StehmanR J Barrett
Aug 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P BonomiF J Major
Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W P McGuireG Photopulos
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G A OmuraB Anderson
Apr 2, 1998·Cancer Chemotherapy and Pharmacology·S RomanelliF Zunino
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H MooreThomas F Rocereto

❮ Previous
Next ❯

Citations

Oct 27, 2010·Cancer Chemotherapy and Pharmacology·Maki TaniokaYasuhiro Fujiwara
Apr 6, 2013·Cancer Chemotherapy and Pharmacology·Mayu YunokawaYasuhiro Fujiwara
Feb 25, 2010·Archives of Gynecology and Obstetrics·Linda HertleinKlaus Friese
Jun 22, 2010·Archives of Gynecology and Obstetrics·Gustavo Cardoso GuimarãesAdemar Lopes
Dec 17, 2011·Archives of Gynecology and Obstetrics·Jong Ha HwangJoo-Young Kim
Oct 26, 2012·International Journal of Clinical Oncology·Tatsuru OharaNao Suzuki
Oct 14, 2005·Current Oncology Reports·Krishnansu S Tewari, Bradley J Monk
Nov 3, 2010·Current Oncology Reports·Ann H Klopp, Patricia J Eifel
Oct 16, 2013·Current Oncology Reports·Kathryn Graham, Kevin Burton
Mar 26, 2013·Journal of Chemical Information and Modeling·Peichen PanTingjun Hou
Feb 2, 2010·Nature Reviews. Clinical Oncology·David O Holtz, Charles J Dunton
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ColomboUNKNOWN ESMO Guidelines Working Group
Aug 9, 2006·Current Opinion in Oncology·David H Moore
Jan 29, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hassan ErrihaniIbrahim Elghissassi
Feb 22, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Takeshi HisamatsuTadashi Kimura
Feb 13, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S M MourtonD S Chi
May 1, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·G PanekM Bidzinski
Jun 2, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H W HirteA M Oza
Nov 14, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S AckermannT Bogenrieder
Sep 26, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K Y LookUNKNOWN Gynecologic Oncology Group Study
Apr 17, 2013·BMC Cancer·David J Stewart, Razelle Kurzrock
Dec 7, 2010·World Journal of Surgical Oncology·Rani KanthanDana Diudea
Jan 14, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J MonkLynda D Roman
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J MonkDavid Cella
Dec 8, 2009·The Tohoku Journal of Experimental Medicine·Shin Wha LeeYoung-Tak Kim
Mar 9, 2010·Drugs·Alfonso Dueñas-GonzálezDéborah Martínez-Baños
Feb 21, 2014·The New England Journal of Medicine·Krishnansu S TewariBradley J Monk
Jan 17, 2014·Current Treatment Options in Oncology·Angel ChaoChyong-Huey Lai
Apr 5, 2014·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Aline BeckenkampAndréia Buffon
Jul 27, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A PovedaA González Martín
Jun 23, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Ana OakninUNKNOWN SEOM (Spanish Society of Clinical Oncology)
Mar 13, 2009·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·B PiuraR Shaco-Levy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.